-
Webinar-$AFMD Data Explained + Chinese Trade & A lot More Commentary
Webinar-$AFMD Data Explained + Chinese Trade & A lot More Commentary
-
Commentary Premium Articles, Commentary Premium Videos, Premium Articles, Premium Videos
Video Chart Reviews + $SPY + Market Commentary & Other Plays
In this chart video review, I begin by talking about the overall market view in which I’m not wild about the $SPY chart, and think we can test the lows of the year here because of the current potential ‘star’ formation. However, we can get a ‘W’ type rally as well, but liquidity is border […]
-
Commentary Premium Articles, Premium Articles
Weekend Update – NKTR, TSRO, SPY, TLT
Happy Monday Futures were up early overnight and have since faded in the EU session. Based on the ES daily chart we are in the consolidation range for an inverted head and shoulders break out move. If we are red, it should only be for one more day here. Bond leverages look in tact as […]
-
Weekend update
Suprisingly quiet weekend in terms of headlines as we are gearing up for midterms on Tuesday. Expect a lot of noise for the next 48 hours in the market, this tape has not been an easy one to trade with many fakeouts on nearer timeframes. Copper has performed very well recently and would seem to […]
-
Commentary Premium Articles, Commentary Premium Videos, Premium Articles, Premium Videos
Video Chart Reviews + Commentary – $AFMD $CALA $MGEN $SPY $QQQ + More
Video Chart Reviews + Commentary – $AFMD $CALA $MGEN $SPY $QQQ + More
-
Commentary Premium Articles, Premium Articles
Evening Update – $XLNX $SPY $QQQ $IWM $SMH $XBI $SPGI $BLK $AMD
Good Evening All, Markets continued to sell-off today as we broke under the prior lows across the board for the SPY, QQQ, IWM and risk on sectors such as Semiconductors (SMH) and Biotechs (XBI). This was largely a rotational sell-off however as money flowed into what are typically viewed as safe-havens such as bonds, utilities […]
-
Webinar – ESMO Data Covered + Market Commentary
Webinar – ESMO Data Covered + Market Commentary
-
Commentary Premium Articles, Commentary Premium Videos, Premium Articles, Premium Videos
Audio Commentary – Market Craziness Explained + $CALA $AFMD & More
Audio Commentary – Market Craziness Explained + $CALA $AFMD & More
-
Commentary Premium Articles, Premium Articles
$AFMD Trial Halt News Recap
This evening Affimed reported that the company placed its AFM11 trial on a clinical holding following the discovery of a death as well as two life-threatening adverse events all at the highest dose tested to date. As can be expected with this management team, the press release did little to elaborate on the details of […]
-
Webinar – $CALA In Depth + Potential Market Issues Discussed
In this webinar, we begin by discussing $CALA’s R&D day from last Friday. We heard a lot that we like, and think the company is headed in the right direction. Here, we discuss all the positives we heard that confirms our view that in time, CALA should be a big winner. Having said that… Danny […]